• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨肉瘤、软骨肉瘤和尤文肉瘤治疗策略的综述。

Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.

机构信息

Department of Orthopedic Surgery, 1st Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

出版信息

Med Sci Monit. 2011 Aug;17(8):RA177-190. doi: 10.12659/msm.881893.

DOI:10.12659/msm.881893
PMID:21804475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3539609/
Abstract

The most prevalent forms of bone cancer are osteosarcoma, chondrosarcoma, and Ewing's sarcoma. Although chemotherapy and radiotherapy have replaced traditional surgical treatments, survival rates have undergone only marginal improvements. Current knowledge of the molecular pathways involved in each type of cancer has led to better approaches in cancer treatment. A number of cell signaling molecules are involved in tumorigenesis, and specific targets have been identified based on these signal transducers. This review highlights some of the important cellular pathways and potential therapeutic targets, tumor site-specific irradiation techniques, and novel drug delivery systems used to administer these drugs.

摘要

最常见的骨癌类型包括骨肉瘤、软骨肉瘤和尤文肉瘤。尽管化疗和放疗已经取代了传统的手术治疗,但生存率仅略有提高。目前对每种癌症相关分子途径的认识已经导致了更好的癌症治疗方法。许多细胞信号分子参与肿瘤发生,并且已经基于这些信号转导物确定了特定的靶标。本综述强调了一些重要的细胞途径和潜在的治疗靶点、肿瘤部位特异性照射技术以及用于给予这些药物的新型药物输送系统。

相似文献

1
Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.骨肉瘤、软骨肉瘤和尤文肉瘤治疗策略的综述。
Med Sci Monit. 2011 Aug;17(8):RA177-190. doi: 10.12659/msm.881893.
2
Experimental therapies and clinical trials in bone sarcoma.骨肉瘤的实验治疗和临床试验。
J Natl Compr Canc Netw. 2010 Jun;8(6):715-25. doi: 10.6004/jnccn.2010.0052.
3
Pelvic bone sarcomas: controversies and treatment options.骨盆骨肉瘤:争议与治疗选择。
J Natl Compr Canc Netw. 2010 Jun;8(6):731-7. doi: 10.6004/jnccn.2010.0053.
4
What's new in primary bone tumors.原发性骨肿瘤有哪些新进展。
J Bone Joint Surg Am. 2012 Oct 17;94(20):1913-9. doi: 10.2106/JBJS.L.00955.
5
Magnetic resonance imaging in malignant bone tumours.恶性骨肿瘤的磁共振成像
Int Orthop. 1990;14(1):49-55. doi: 10.1007/BF00183365.
6
EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma.EphA2 在骨肉瘤中的表达:骨肉瘤、尤文肉瘤和软骨肉瘤患者来源模型的生物信息学分析和临床前特征。
Cells. 2021 Oct 26;10(11):2893. doi: 10.3390/cells10112893.
7
Current trends in the diagnosis and treatment of malignant bone tumors.恶性骨肿瘤诊断与治疗的当前趋势
Clin Orthop Relat Res. 1983 Nov(180):220-52.
8
Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.临床前证据表明,TRAIL 在尤文肉瘤和骨肉瘤治疗中的应用可抑制肿瘤生长、防止溶骨性骨破坏,并提高动物生存率。
Clin Cancer Res. 2010 Apr 15;16(8):2363-74. doi: 10.1158/1078-0432.CCR-09-1779. Epub 2010 Apr 6.
9
Update on targets and novel treatment options for high-grade osteosarcoma and chondrosarcoma.高级骨肉瘤和软骨肉瘤的治疗靶点和新型治疗选择的最新进展。
Hematol Oncol Clin North Am. 2013 Oct;27(5):1021-48. doi: 10.1016/j.hoc.2013.07.012. Epub 2013 Aug 26.
10
Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.骨肉瘤、软骨肉瘤和尤因肉瘤:国家癌症数据库报告。
Clin Orthop Relat Res. 2007 Jun;459:40-7. doi: 10.1097/BLO.0b013e318059b8c9.

引用本文的文献

1
Radiosensitizing Effect of PARP Inhibition on Chondrosarcoma and Chondrocyte Cells Is Dependent on Radiation LET.PARP 抑制对软骨肉瘤和软骨细胞的放射增敏作用依赖于射线的线性能量传递。
Biomolecules. 2024 Aug 27;14(9):1071. doi: 10.3390/biom14091071.
2
Chondrosarcoma in Proximal Humerus: The First Reported Case in Lebanon and the Middle East of a Female Treated with MUTARS® Shoulder Hemiarthroplasty.肱骨近端软骨肉瘤:黎巴嫩及中东地区首例采用MUTARS® 半肩关节置换术治疗的女性病例报告
J Orthop Case Rep. 2024 Sep;14(9):116-124. doi: 10.13107/jocr.2024.v14.i09.4750.
3
Chondrosarcoma Resistance to Radiation Therapy: Origins and Potential Therapeutic Solutions.

本文引用的文献

1
Imaging assessment of osteosarcoma in childhood and adolescence: diagnosis, staging, and evaluating response to chemotherapy.儿童和青少年骨肉瘤的影像学评估:诊断、分期及化疗反应评估
Cancer Treat Res. 2009;152:33-62. doi: 10.1007/978-1-4419-0284-9_3.
2
Bone sarcomas: Overview of management, with a focus on surgical treatment considerations.骨肉瘤:治疗管理概述,重点关注手术治疗的考虑因素。
Cleve Clin J Med. 2010 Mar;77 Suppl 1:S8-12. doi: 10.3949/ccjm.77.s1.02.
3
Tenascin-C as a prognostic biomarker in osteosarcoma?Tenascin-C 作为骨肉瘤的预后生物标志物?
软骨肉瘤对放射治疗的抗性:起源与潜在治疗方案
Cancers (Basel). 2023 Mar 24;15(7):1962. doi: 10.3390/cancers15071962.
4
Integration of single-cell RNA sequencing and bulk RNA sequencing to reveal an immunogenic cell death-related 5-gene panel as a prognostic model for osteosarcoma.单细胞 RNA 测序和批量 RNA 测序的整合揭示了一个免疫原性细胞死亡相关的 5 个基因panel 作为骨肉瘤的预后模型。
Front Immunol. 2022 Sep 26;13:994034. doi: 10.3389/fimmu.2022.994034. eCollection 2022.
5
The hEag1 K Channel Inhibitor Astemizole Stimulates Ca Deposition in SaOS-2 and MG-63 Osteosarcoma Cultures.依巴斯汀(一种 hEag1 K 通道抑制剂)可刺激 SaOS-2 和 MG-63 骨肉瘤细胞的钙沉积。
Int J Mol Sci. 2022 Sep 11;23(18):10533. doi: 10.3390/ijms231810533.
6
Cranial internal hemipelvectomy (iliectomy) with limb sparing for a dog with ilial chondrosarcoma: A case report.犬髂骨软骨肉瘤行保肢的颅骨内半骨盆切除术(髂骨切除术):病例报告
Clin Case Rep. 2022 Jan 11;10(1):e05262. doi: 10.1002/ccr3.5262. eCollection 2022 Jan.
7
Targeting Farnesoid X receptor (FXR) for developing novel therapeutics against cancer.靶向法尼酯X受体(FXR)开发抗癌新疗法。
Mol Biomed. 2021 Jul 10;2(1):21. doi: 10.1186/s43556-021-00035-2.
8
A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors.HER4(ErbB4)激酶综述:其对癌症的影响及其抑制剂。
Molecules. 2021 Dec 5;26(23):7376. doi: 10.3390/molecules26237376.
9
NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma.NLRP3过表达与骨肉瘤预后不良相关并作为骨肉瘤的有效治疗靶点
Front Pharmacol. 2021 Jul 28;12:724923. doi: 10.3389/fphar.2021.724923. eCollection 2021.
10
Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways.抑制 BUB1 通过阻断 PI3K/Akt 和 ERK 通路抑制骨肉瘤的发生。
J Cell Mol Med. 2021 Sep;25(17):8442-8453. doi: 10.1111/jcmm.16805. Epub 2021 Aug 1.
Chin Med J (Engl). 2009 Nov 20;122(22):2737-43.
4
Prognostic value of immunohistochemistry in the Ewing's sarcoma family of tumors.免疫组化在尤因肉瘤家族性肿瘤中的预后价值
Med Sci Monit. 2009 Aug;15(8):CR442-52.
5
Phase I/II and phase II studies of targeted gene delivery in vivo: intravenous Rexin-G for chemotherapy-resistant sarcoma and osteosarcoma.体内靶向基因递送的I/II期和II期研究:静脉注射Rexin-G治疗化疗耐药性肉瘤和骨肉瘤。
Mol Ther. 2009 Sep;17(9):1651-7. doi: 10.1038/mt.2009.126. Epub 2009 Jun 16.
6
An integrative multi-platform analysis for discovering biomarkers of osteosarcoma.一项用于发现骨肉瘤生物标志物的综合多平台分析。
BMC Cancer. 2009 May 16;9:150. doi: 10.1186/1471-2407-9-150.
7
Novel therapeutic agents for osteosarcoma.骨肉瘤的新型治疗药物。
Expert Rev Anticancer Ther. 2009 Apr;9(4):511-23. doi: 10.1586/era.09.7.
8
Curettage with pasteurization in situ for grade 1 chondrosarcoma - long-term follow up study of less invasive surgical procedure.原位刮除加巴氏消毒治疗1级软骨肉瘤——微创外科手术的长期随访研究
Med Sci Monit. 2009 Mar;15(3):CS44-8.
9
Osteosarcoma treatment: state of the art.骨肉瘤治疗:最新进展
Cancer Metastasis Rev. 2009 Jun;28(1-2):247-63. doi: 10.1007/s10555-009-9186-7.
10
Identification of cancer stem cells in Ewing's sarcoma.尤因肉瘤中癌症干细胞的鉴定。
Cancer Res. 2009 Mar 1;69(5):1776-81. doi: 10.1158/0008-5472.CAN-08-2242. Epub 2009 Feb 10.